Open access journal
Hypertensive Encephalopathy Associated with Suspected Post-mumps Glomerulonephritis in an Adolescent Male: A Rare Case Report
By B. B. Likhitha, Shranga Gopal Chandan and Rakshith Raj Chandan.
Abstract
Aims
We report an adolescent male with severe hypertensive encephalopathy and generalised tonic-clonic seizures as a rare and emergent paediatric complication occurring in the setting of suspected post-mumps acute glomerulonephritis (AGN). Presentation of Case: A previously well 15-year-old adolescent male presented with a 7-day history of intermittent fever, progressive throbbing headache, intermittent non-bilious vomiting, visual blurring, and two generalised tonic-clonic seizures. He reported a history of tender bilateral parotitis 5–6 days earlier, which had regressed spontaneously. On presentation to the ED, he had a severe hypertensive crisis with a blood pressure (BP) of 180/104 mmHg (>99th percentile + 30 mmHg) and sinus bradycardia (52–55 bpm), with evidence of Cushing’s reflex. Examination revealed moderate periorbital facial puffiness without peripheral oedema. A non-contrast computed tomography scan of the brain showed no intracerebral haemorrhage or gross structural abnormality. Investigations showed 17–19 RBC/HPF on urinalysis, with dipstick blood 2+, microscopic haematuria, proteinuria, CRP 6.50 mg/L, and positive serum mumps IgM at 1:160, while serum creatinine (0.76 mg/dL) and urea (18 mg/dL) remained normal. Bilateral renal Doppler ultrasonography revealed structurally normal renal parenchyma with a normal resistive index (0.50–0.70) and no renal artery stenosis. On admission to the PICU, a continuous intravenous labetalol infusion was started (0.25 mg/kg/hr, titrated to achieve a 25% reduction in mean blood pressure over 6–8 hours), together with intravenous levetiracetam (20 mg/kg/day), mannitol, and furosemide to correct volume overload. His blood pressure and neurological condition improved within 48–72 hours, and he was subsequently discharged after transition to oral amlodipine (5 mg OD), without neurological or renal sequelae.



